333 related articles for article (PubMed ID: 30633886)
1. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
Li J; Qi Y
Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.
Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H
Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.
Shang A; Wang W; Gu C; Chen W; Lu W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8301-8320. PubMed ID: 32380476
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
5. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
7. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells.
Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R
Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803
[TBL] [Abstract][Full Text] [Related]
8. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
Zhao D; Sui Y; Zheng X
Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
[TBL] [Abstract][Full Text] [Related]
9. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
Yang T; Zhai H; Yan R; Zhou Z; Gao L; Wang L
Braz J Med Biol Res; 2018; 51(6):e7046. PubMed ID: 29791590
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
Sun M; Shen Z
Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells.
Pan XY; Guo H; Han J; Hao F; An Y; Xu Y; Xiaokaiti Y; Pan Y; Li XJ
Eur J Pharmacol; 2012 May; 683(1-3):27-34. PubMed ID: 22426160
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
15. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.
Li Y; Lu J; Bai F; Xiao Y; Guo Y; Dong Z
Biomed Res Int; 2018; 2018():4306579. PubMed ID: 29750154
[TBL] [Abstract][Full Text] [Related]
19. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
Abuduer M; A EZG
Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
[TBL] [Abstract][Full Text] [Related]
20. Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19.
Bi Y; Fu Y; Wang S; Chen X; Cai X
Braz J Med Biol Res; 2019; 52(10):e8385. PubMed ID: 31618367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]